DRP1-dependent mitochondrial fission promotes pulmonary vascular remodeling via activating autophagy, indicating that DNM1L might be a therapeutic target for the treatment of PAH [44]. This evidence concerns the gene DNM1L and pulmonary arterial hypertension.